Stock ZALICUS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Zalicus Inc Nasdaq

Equities

US98887C1053

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Zalicus Inc
2018 Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc. CI
2018 Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q). CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. EPRSQ Stock
  4. Stock
  5. News Zalicus Inc
  6. Official Publications
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW